Get the Stockscreener App
0.307
5.83%
-0.019
Acurx Pharmaceuticals Inc stock is traded at $0.307, with a volume of 1.01M.
It is down -5.83% in the last 24 hours and down -37.47% over the past month.
Acurx Pharmaceuticals Inc is a clinical stage biopharmaceutical company developing a new class of antibiotics for infections caused by bacteria listed as priority pathogens by the World Health Organization, Centers for Disease Control and Prevention and Food and Drug Administration. The company's approach is to develop antibiotic candidates with a Gram-positive selective spectrum. The Company's segment consists of the development of clinical and preclinical product candidates for the development of the Company's proprietary new therapies.
See More
Previous Close:
$0.326
Open:
$0.321
24h Volume:
1.01M
Relative Volume:
0.17
Market Cap:
$9.10M
Revenue:
-
Net Income/Loss:
$-14.58M
P/E Ratio:
-0.267
EPS:
-1.15
Net Cash Flow:
$-9.80M
1W Performance:
-24.37%
1M Performance:
-37.47%
6M Performance:
-57.98%
1Y Performance:
-85.65%
1-Day Range:
$0.2907
$0.3226
1-Week Range:
$0.2907
$0.4326
52-Week Range:
$0.2907
$2.39
Acurx Pharmaceuticals Inc Stock (ACXP) Company Profile
Name
Acurx Pharmaceuticals Inc
Sector
Industry
Phone
917-533-1469
Address
259 LIBERTY AVENUE, STATEN ISLAND
Compare ACXP with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ACXP
Acurx Pharmaceuticals Inc
|
0.307 | 9.66M | 0 | -14.58M | -9.80M | -1.15 |
|
VRTX
Vertex Pharmaceuticals Inc
|
462.13 | 117.32B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
558.87 | 58.89B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
401.80 | 51.14B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
673.80 | 41.02B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
299.01 | 32.59B | 3.81B | -644.79M | -669.77M | -6.24 |
Acurx Pharmaceuticals Inc Stock (ACXP) Latest News
Heatmap analysis for Acurx Pharmaceuticals Inc. and competitorsPrice Action Summary and Entry Strategy Guide - Newser
What makes Acurx Pharmaceuticals Inc. stock price move sharplyLong-Term Safety Investment Analysis Report - Newser
Why Acurx Pharmaceuticals Inc. stock attracts strong analyst attentionDaily Exit and Entry Price Prediction - Newser
Company’s Banking Shares: Up -87.00% from 52-Week Low, But Can the Momentum Hold? - investchronicle.com
How does Acurx Pharmaceuticals Inc. compare to its industry peersLow Risk Forecasts For Beginners - jammulinksnews.com
Why is Acurx Pharmaceuticals Inc. stock attracting strong analyst attentionPre Market Review For Consistent Profits - jammulinksnews.com
What are analysts’ price targets for Acurx Pharmaceuticals Inc. in the next 12 monthsSwing Trade Updates To Watch Now - jammulinksnews.com
Should I hold or sell Acurx Pharmaceuticals Inc. stock in 2025Top Growth Tracker With Low Risk - jammulinksnews.com
How Acurx Pharmaceuticals Inc. stock performs during market volatilityAI-Based Reversal Point Prediction Signal - Newser
Multi asset correlation models including Acurx Pharmaceuticals Inc.Swing Gain Strategy with Entry Forecast - Newser
How moving averages guide Acurx Pharmaceuticals Inc. tradingFree AI Forecast for Trending Stocks - Newser
Technical signs of recovery in Acurx Pharmaceuticals Inc.Value Investing Summary and Earnings Outlook - Newser
Acurx Pharmaceuticals Approves Reverse Stock Split to Regain Nasdaq Compliance - AInvest
What institutional investors are buying Acurx Pharmaceuticals Inc. stockPost Market Updates For Consistent Profits - jammulinksnews.com
Acurx Pharmaceuticals Announces 1-For-20 Reverse Stock Split, Trading Post-Split On August 5, 2025 - 富途牛牛
Acurx Pharmaceuticals Plans Major 1:20 Reverse SplitKey Details for Nasdaq Compliance - Stock Titan
Can volume confirm reversal in Acurx Pharmaceuticals Inc.Free Daily Top Performing Stock Insights - Newser
What risks could impact Acurx Pharmaceuticals Inc. stock performanceStock Portfolio Risk and Return Analysis - Newser
Sector Rotation Brings Acurx Pharmaceuticals Inc. Into FocusTriple Digit Return Stock Predictions Released - metal.it
Can Acurx Pharmaceuticals Inc. Regain Lost Ground This QuarterRisk Managed Intraday Trade Alerts Increase in Volume - metal.it
Published on: 2025-07-29 10:12:38 - metal.it
Acurx Pharmaceuticals Inc. Rebound Backed by Sentiment ShiftWatchlist for Smart Swing Trading Updated - metal.it
How strong is Acurx Pharmaceuticals Inc. company’s balance sheetSwing Trade Entry Points For Fast Growth - jammulinksnews.com
Does Acurx Pharmaceuticals Inc. stock perform well during market downturnsExceptional stock performance - jammulinksnews.com
What high frequency data says about Acurx Pharmaceuticals Inc.Intraday Price Forecast Using Volume Models - Newser
Is Acurx Pharmaceuticals Inc. stock overvalued or undervaluedPost Market Recommendation For 2025 - jammulinksnews.com
What are the latest earnings results for Acurx Pharmaceuticals Inc.Maximize portfolio growth with professional advice - jammulinksnews.com
What are Acurx Pharmaceuticals Inc. company’s key revenue driversAchieve rapid capital gains with smart investing - jammulinksnews.com
Moving Average Trends for Acurx Pharmaceuticals Inc. Stock: What They IndicateInstant Stock Updates - Newser
Is Acurx Pharmaceuticals Inc. a good long term investmentOutstanding risk-reward balance - PrintWeekIndia
What drives Acurx Pharmaceuticals Inc. stock priceHigh-margin investment plays - PrintWeekIndia
Acurx Pharmaceuticals Faces AI-Driven Challenges Amid Regulatory and Cybersecurity Concerns - TipRanks
What analysts say about Acurx Pharmaceuticals Inc. stockFree Predictions - PrintWeekIndia
Acurx Pharmaceuticals Inc Stock (ACXP) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.93%
0.15%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):